| Sep 3 |
Valneva and Pfizer Report Further Positive Phase 2 Booster Results for Lyme Disease Vaccine Candidate
|
| Sep 2 |
Wall Street Analysts Predict a 150.41% Upside in Valneva (VALN): Here's What You Should Know
|
| Aug 20 |
High Growth Tech Stocks in France Featuring Lectra and Two More
|
| Aug 19 |
Why Nikola Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session
|
| Aug 15 |
How Much Upside is Left in Valneva (VALN)? Wall Street Analysts Think 135.3%
|
| Aug 13 |
Valneva reports 1H results
|
| Aug 13 |
Valneva Reports Half Year 2024 Financial Results and Provides Corporate Updates
|
| Aug 6 |
VALNEVA - Declaration of shares and voting rights: July 31, 2024
|
| Aug 1 |
Valneva and LimmaTech partner for shigellosis vaccine development
|
| Aug 1 |
Valneva and LimmaTech Enter into a Strategic Partnership to Accelerate the Development of the World’s Most Clinically Advanced Tetravalent Shigella Vaccine Candidate
|
